COVID-19 vaccines and therapeutics spending decline

Annual decline in spending on COVID-19 vaccines and antiviral therapeutics.

Unit billion USD Industry Pharmaceuticals

Records
1
Regions
1
Period
2025
Sources
1
Verification 1 verified data points Updated 15 Sep 2026 Last verified 15 Sep 2026 Next update Sources typically refresh annually

The chart

The figure

One published observation so far. A chart follows as soon as a second period is published.

COVID-19 vaccines and therapeutics spending decline

United States, 2025

1 observation
4 billion USD United States · 2025 · IQVIA · full record
Source: IQVIA · CC BY 4.0 · statorigin.org

Every record

All records

1 record · 1 region · 2025

COVID-19 vaccines and therapeutics spending decline: every record, grouped by region, newest first.
Period Value Source Type
United States 1 record
2025 4 billion USD IQVIA · 31 Dec 2025 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
U.S. Medicine Use Trends 2026 IQVIA 1

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). COVID-19 vaccines and therapeutics spending decline. Retrieved from https://statorigin.org/indicators/covid-19-vaccines-and-therapeutics-spending-decline